e-ISSN: Pending
Negative / Null Result ReportOpen accessVeterinary medicine

The incidence and trends of proteinuria, azotemia and hypertension in cats receiving toceranib phosphate

Kimberly Williams; Valerie MacDonald-Dickinson; Arata Matsuyama · 2024 · Journal of Feline Medicine and Surgery

WASTE classifies this as Negative / Null Result Report · AI classification, approximate

The study found no significant effect — useful as a negative control or null benchmark for your own design.

Abstract

Objectives This retrospective study aimed to determine the incidence and trends of proteinuria, elevations in serum creatinine and urea, and systolic blood pressure in cats undergoing treatment with toceranib. Methods In total, 32 cats treated with toceranib for malignancies were analyzed. Cats were included if urinalysis and urine protein:creatinine ratio (UPC) measurements were available at 28 days (T1) and 56 days (T2) after starting the treatment. Cats with concurrent lower urinary tract disease, including urinary tract malignancy, were excluded. Friedman’s ANOVA compared variables between

Abstract by Kimberly Williams; Valerie MacDonald-Dickinson; Arata Matsuyama, Journal of Feline Medicine and Surgery (2024) — licensed CC BY 4.0.

About to run something similar?

Run an AI Precheck on your own design to catch failure modes like this one before you spend the time. Your first desk check is free.

WASTE indexes this work — it does not host or republish it. Failure-type classification is automated and approximate.

Metadata source: DOAJ · DOI 10.1177/1098612x241266418